Clinical Trials

Without lung cancer clinical trials, the most exciting advances in lung cancer treatment would not have been possible. Research shows these new therapies have made a big difference as lung cancer death rates continue their dramatic fall and survival rates increase.

At Penn Medicine Lancaster General Health, our patients have been among the first in the U.S. to have access to lifesaving new treatments like immunotherapy and targeted therapy. And because our doctors are active researchers and principal investigators on many lung cancer clinical trials, our patients remain first in line for what’s next.

Learn more about cancer research and clinical trials at Lancaster General Health.

Lung Cancer Research: The Penn Medicine Lancaster General Health Advantage

When you come to us for lung cancer care, you receive evidence-backed treatments, some of which we helped develop. These therapies have transformed the lung cancer treatment landscape and include:

• Immunotherapy: Our patients received early access to immunotherapy before it was FDA-approved in 2015.
• Dual immunotherapy plus chemotherapy: We continue to give our patients access to new immunotherapy drugs and regimens before they are widely available, including dual immunotherapy. Patients received dual immunotherapy plus chemotherapy in a non-small cell lung cancer clinical trial. The regimen was recently FDA-approved. In dual immunotherapy, one drug boosts the body's immune defenses while the other attacks cancer immune cells.

How to Get Involved with a Lung Cancer Clinical Trial

When you choose Penn Medicine Lancaster General Health for your lung cancer treatment, you are automatically screened for clinical trial eligibility. Your treatment plan starts with your best option, which may be a new drug or treatment regimen.

You may participate in a non-small cell or small cell lung cancer clinical trial:

• At Ann B. Barshinger Cancer Institute in Lancaster
• At Penn Medicine in Philadelphia
• Virtually using telemedicine for a trial in Lancaster or Philadelphia
• At another institution outside of our system

Get information on current clinical trials open for participation.

Request an Appointment

To make an appointment at the Ann B. Barshinger Cancer Institute, call 717-544-9400 or request an appointment using our online form.